Drugs / Bivalent killed oral cholera vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00548054 | Dec 2015 → Aug 2016 | cholera, diarrheal disease | International Vaccine Institute | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bivalent killed oral cholera vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00548054 ↗ |
| Modality | Vaccine | “killed oral cholera vaccine” NCT00548054 ↗ |
| Route | Oral | “Oral, 1.5 ml, given 2 times at least 14 days apart” NCT00548054 ↗ |